-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
IMB-26
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1001426-49-8.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 1001426-49-8 |
| Description | IMB-26 is a HCV inhibitor with an EC50 of 2.1 μM. IMB-26 shows potent an anti-HCV activity. |
Product Information
| Synonyms | IMB-26|CHEMBL247195|SCHEMBL17512412|HY-115988|CS-0434733|3-(2-bromopropanoylamino)-4-methoxy-N-(3,4,5-trimethoxyphenyl)benzamide|([3-(alpha-bromopropionyl)amino-4-methoxybenzene]formyl-(3,4,5-trimethoxybenzene) amide |
| Molecular Weight | 467.31 |
| Molecular Formula | C20H23BrN2O6 |
| Canonical SMILES | CC(C(=O)NC1=C(C=CC(=C1)C(=O)NC2=CC(=C(C(=C2)OC)OC)OC)OC)Br |
| Boiling Point | 572.8±50.0 °C at 760 mmHg |
| Flash Point | 300.2±30.1 °C |
| Purity | ≥98% (HPLC) |
| Density | 1.4±0.1 g/cm3 |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 537 |
| Exact Mass | 466.07395 |
| Index Of Refraction | 1.592 |
| Target | EC50: 2.1 μM (HCV) |
| Vapor Pressure | 0.0±1.6 mmHg at 25°C |
| XLogP3-AA | 3 |
